Tocilizumab, an anti-interleukin-6 receptor antibody, has garnered Emergency Use Authorization (EUA) from the FDA for hospitalized adult or paediatric patients necessitating systemic corticosteroids or mechanical ventilation [10]
This is where MeAgain's GLP-1 app fits in, addressing dosing consistency, symptom logging, and protein and hydration tracking so clinicians get time-stamped data to guide titration and troubleshooting
These adjustments seem to improve the peptide's pharmacokinetic properties
Adults and children over 16 years of age, one to two tablets daily on an empty stomach, can be increased to three tablets if required
Taking breaks between cycles allows assessment of whether continued use remains necessary and gives the body time to normalize
In some circumstances patients may not be able to tolerate the higher doses of Mounjaro, but they can still experience benefit on a lower dose